At Sana, we are fortunate to have incredible women in leadership roles. In honor of #WomensEqualityDay Sana’s Women’s ERG, EmpowHER, facilitated a panel discussion composed of women across our business operations team who shared their own journey, insight, and perspective on navigating careers within biotechnology. We understand that representation matters and ensure we do our part to drive equality in biotech. #mentorship #womeninscience #WomensEqualityDay #sana
Sana Biotechnology, Inc.
Biotechnology Research
Seattle, Washington 39,614 followers
Focused on creating and delivering engineered cells as medicines for patients
Über uns
Sana Biotechnology is focused on utilizing engineered cells as medicines for patients. The ability to modify genes and use cells as medicines will be one of the most important advances in healthcare over the next several decades. Sana is building differentiated capabilities across the spectrum of cell and gene therapy. Three aspirations drive Sana as we look to discover treatments for patients with poor outcomes or currently untreatable diseases. The first is the ability to repair and control the genes in any cell in the body. We are advancing novel delivery technologies with the goal of being able to deliver any payload to any cell in a specific, predictable, and repeatable manner, paving the way for next-generation in vivo gene therapy. Next is the ability to differentiate pluripotent stem cells ex vivo into immune-cloaked functional cells with the aspiration of being able to replace any missing or damaged cells in the body. Last is a belief we can enable broader access to our therapies through focusing on scalable manufacturing solutions, the cost of manufacturing, and aligning with key stakeholders. Sana launched in early 2019 and has over 350 employees in Seattle, Cambridge, and South San Francisco. Sana was founded with the long view – bringing together great people and the best technologies to deliver on the challenging promise of using engineered cells to meaningfully change the outcome of many human diseases.
- Website
-
http://sana.com
External link for Sana Biotechnology, Inc.
- Industrie
- Biotechnology Research
- Größe des Unternehmens
- 201-500 Mitarbeiter
- Hauptsitz
- Seattle, Washington
- Typ
- Öffentliches Unternehmen
- Gegründet
- 2018
Standorte
-
Primäre
188 E Blaine St
Suite 400
Seattle, Washington 98102, US
-
1 Tower Pl
Suite 500
South San Francisco, California 94080, US
-
300 Technology Sq
Suite 700
Cambridge, Massachusetts 02139, US
Employees at Sana Biotechnology, Inc.
Aktualisierungen
-
There is nothing better for our health and well-being than taking time to recharge. At Sana, we get joy watching our colleagues take advantage of our unique and flexible time-off benefits that allow our team to explore new experiences, travel, connect with family, volunteer, or just chill at home. #worklifebalance #Sana #culture #thriveatsana #wanderlust
-
-
We are thrilled to announce the grand opening of our manufacturing facility in Bothell, WA. This new facility is set to produce life-saving medicines, create numerous jobs, and stimulate economic growth in the Bothell region. Reaching this milestone propels us closer to our bold mission of developing engineered cells as medicines. A heartfelt thank you to all the local representatives, community guests, and media for their support! #Sanabiotechnology #Cellengineering #CellTherapy #BothellWashington #Bothell
-
-
Congratulations to Flagship Pioneering on raising $3.6 billion to advance critical innovations that propel human health. The industry is at a transformative juncture in our approach to creating new medicines, with incredible scientific breakthroughs and more to come in growing fields such as cell therapy and artificial intelligence. As a company co-founded by Flagship, we appreciate their bold vision for the future of innovative medicines.
Flagship Pioneering raises $3.6 billion to fuel critical breakthroughs in human health and sustainability. This expanded capital pool will accelerate the impact of original science and the creation and development of an estimated 25 breakthrough companies in human health, sustainability, and artificial intelligence. Hear from Flagship Founder and CEO Noubar Afeyan about how we're taking #BiggerLeaps by leveraging the power of generative AI, forging novel partnerships with pharma to speed drug development, expanding globally, and promoting and hiring top talent to our leadership ranks. Read the full press release: https://bit.ly/4eQfx05
-
Wishing everyone a joyful and safe Independence Day! #4thofJuly #IndependenceDay
-
-
"Juneteenth has never been a celebration of victory, or an acceptance of the way things are. Instead, it's a celebration of progress. It's an affirmation that despite the most painful parts of our history, things do get better. America can change." — Barack Obama, 44th President of the United States, Civil Rights Attorney #Juneteenth #DiversityMatters
-
-
Pride month is not only a time to celebrate and honor Sana’s LGBTQIA+ employees and community, but also a time to acknowledge that there is still more work to be done to support equal rights. At Sana, we aspire to change the possible for patients, regardless of gender, identity, or sexual orientation. #Pride #Inclusivity #Kindness #LGBTQIA #DiversityMatters
-
-
We’re excited to sponsor the Federation of American Societies for Experimental Biology (FASEB)’s Genome Engineering: Research and Applications conference taking place June 16-20, 2024, in Rome, Italy. The conference will focus on groundbreaking research, innovative tools, and cutting-edge technologies in genome and epigenome editing. The Sana team eagerly anticipates connecting with peers and staying at the forefront of industry advancements. Learn more about the conference here: https://lnkd.in/gzHqfTXB hashtag #GENESRC
-
-
Steve Harr, MD, Sana’s President and CEO, will discuss the latest updates from Sana in a fireside chat at the Goldman Sachs 45th Annual Healthcare Conference on Monday, June 10, 2024 at 2:40 p.m. ET. Listen to the live or archived discussion here: https://lnkd.in/gFnFMcUD #Sanabiotechnology #Cellengineering #CellTherapy
-
Today, we honor the strength and resilience of those who have faced cancer. At Sana, we are dedicated to developing cures for patients with cancer and other serious diseases. Together, we celebrate National Cancer Survivor's Day and commit to a future of hope and healing. #CancerSurvivorsDay #LifeBeyondCancer
-
Ähnliche Seiten
Jobs durchsuchen
Finanzierung
Letzte Runde
Eigenkapital nach dem IPOUS$ 165.0M